New ECG markers for predicting long-term mortality and morbidity in patients receiving cardiac resynchronization therapy

被引:8
|
作者
Kisiel, Roksana [1 ]
Fijorek, Kamil [3 ]
Moskal, Pawel [1 ]
Kukla, Piotr [2 ]
Sondej, Tomasz [1 ]
Czarnecka, Danuta [1 ]
Jastrzebski, Marek [1 ]
机构
[1] Jagiellonian Univ, Dept Cardiol Intervent Electrocardiol & Hypertens, Coll Med, Krakow, Poland
[2] H Klimontowicz Specialist Hosp, Dept Cardiol, Gorlice, Poland
[3] Cracow Univ Econ, Dept Stat, Krakow, Poland
关键词
Cardiac resynchronization therapy; Mortality; Electrocardiogram; LV-paced QRS duration; QRS axis; BUNDLE-BRANCH-BLOCK; HEART-FAILURE; AXIS DEVIATION; QRS MORPHOLOGY; IMPACT; CRT; CARDIOMYOPATHY; PARAMETERS; CRITERIA; LATENCY;
D O I
10.1016/j.jelectrocard.2018.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated prognostic value of four recently proposed ECG markers in patients with cardiac resynchronization therapy (CRT): 1./ pathological preimplantation QRS axis, 2./ increase in QRS amplitude in V3 during biventricular pacing, 3./ negative QRS in V1/V2 during left ventricular (LV)-only pacing, 4./ longer QRS duration during LV-only pacing. A longitudinal cohort study was performed (n = 552). Results: During the 9-year observation period the primary endpoint (death from any cause or urgent heart transplantation) was met in 232 patients. The secondary endpoint of survival free of heart failure hospitalization was met in 292 patients. Long LV-paced QRS and pathological axis predicted unfavorable prognosis in Kaplan-Meier analysis. In multivariable Cox model (functional class, LV ejection fraction, LV end-diastolic dimension, permanent atrial fibrillation, age, gender, heart failure etiology, creatinine level, diabetes mellitus), LV-paced QRS duration remained a significant determinant of both endpoints. The other studied ECG markers lacked independent prognostic value. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:637 / 644
页数:8
相关论文
共 50 条
  • [31] Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy
    Barra, Sergio
    Looi, Khang-Li
    Gajendragadkar, Parag R.
    Khan, Fakhar Z.
    Virdee, Munmohan
    Agarwal, Sharad
    EUROPACE, 2016, 18 (08): : 1187 - 1193
  • [32] Clinical Long-Term Response to Cardiac Resynchronization Therapy Is Independent of Persisting Echocardiographic Markers of Dyssynchrony
    Naegeli, Barbara
    Brunner-La Rocca, Hans-Peter
    Jost, Christine Attenhofer
    Fah-Gunz, Anja
    Maurer, Dominik
    Bertel, Osmund
    Scharf, Christoph
    CARDIOLOGY RESEARCH, 2014, 5 (06) : 163 - 170
  • [33] Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome
    Zweerink, Alwin
    Friedman, Daniel J.
    Klem, Igor
    van de Ven, Peter M.
    Vink, Caitlin
    Biesbroek, P. Stefan
    Hansen, Steen M.
    Emerek, Kasper
    Kim, Raymond J.
    van Rossum, Albert C.
    Atwater, Brett D.
    Nijveldt, Robin
    Allaart, Cornelis P.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2018, 11 (12) : e006767
  • [34] Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Repaired Tetralogy of Fallot: A Multicenter Study
    Ramdat Misier, Nawin
    Moore, Jeremy
    Nguyen, Hoang
    Lloyd, Michael
    Dubin, Anne
    Mah, Douglas
    Czosek, Richard
    Khairy, Paul
    Chang, Philip
    Nielsen, Jens
    Aydin, Alper
    Pilcher, Thomas
    O'Leary, Edward
    Shivkumar, Kalyanam
    de Groot, Natasja
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2024, 17 (03) : E012363
  • [35] Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis
    Liang, Yixiu
    Wang, Jingfeng
    Yu, Ziqing
    Zhang, Mingliang
    Pan, Lei
    Nie, Yuxin
    Su, Yangang
    Ge, Junbo
    JOURNAL OF CARDIOLOGY, 2020, 75 (04) : 432 - 438
  • [36] Patient-assessed short-term positive response to cardiac resynchronization therapy is an independent predictor of long-term mortality
    Reitan, Christian
    Bakos, Zoltan
    Platonov, Pyotr G.
    Hoijer, Carl-Johan
    Brandt, Johan
    Wang, Lingwei
    Borgquist, Rasmus
    EUROPACE, 2014, 16 (11): : 1603 - 1609
  • [37] Association of Body Mass Index With Cardiac Reverse Remodeling and Long-Term Outcome in Advanced Heart Failure Patients With Cardiac Resynchronization Therapy
    Cai, Chi
    Hua, Wei
    Ding, Li-Gang
    Wang, Jing
    Chen, Ke-Ping
    Yang, Xin-Wei
    Liu, Zhi-Min
    Zhang, Shu
    CIRCULATION JOURNAL, 2014, 78 (12) : 2899 - 2907
  • [38] Fluoroscopic Left Ventricular Lead Position and the Long-Term Clinical Outcome of Cardiac Resynchronization Therapy
    Foley, Paul W. X.
    Chalil, Shajil
    Ratib, Karim
    Smith, Russell
    Prinzen, Frits
    Auricchio, Angelo
    Leyva, Francisco
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (07): : 785 - 797
  • [39] The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: Results of the REVERSE study
    Gold, Michael R.
    Daubert, Claude
    Abraham, William T.
    Ghio, Stefano
    Sutton, Martin St. John
    Hudnall, John Harrison
    Cerkvenik, Jeffrey
    Linde, Cecilia
    HEART RHYTHM, 2015, 12 (03) : 524 - 530
  • [40] Predicting Early Mortality Among Implantable Defibrillator Patients Treated With Cardiac Resynchronization Therapy
    Theuns, Dominic A. M. J.
    Van Boven, Nick
    Schaer, Beat A.
    Hesselink, Tim
    Rivero-Ayerza, Maximo
    Umans, Victor
    Sticherling, Christian
    Scholten, Marcoen F.
    Verbrugge, Frederik
    Zijlstra, Felix
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (10) : 812 - 818